20262100: Swedish Orphan Biovitrum AB (publ); Innate Pharma S.A.
HSR Early Termination Notices ·
20262100: Swedish Orphan Biovitrum AB (publ); Innate Pharma S.A. Date September 9, 2026 hbarber September 10, 2026 | 10:22AM Transaction Number 20262100 Acquiring Party Swedish Orphan Biovitrum AB (publ) Acquired Party Innate Pharma S.A. Granting Status Granted Acquired Entities Innate Pharma S.A.
20262100: Swedish Orphan Biovitrum AB (publ); Innate Pharma S.A. Date September 9, 2026 hbarber September 10, 2026 | 10:22AM Transaction Number 20262100 Acquiring Party Swedish Orphan Biovitrum AB (publ) Acquired Party Innate Pharma S.A. Granting Status Granted Acquired Entities Innate Pharma S.A.